Unchained Labs Revenue and Competitors

Location

$285M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Unchained Labs's estimated annual revenue is currently $58.1M per year.(i)
  • Unchained Labs received $17.0M in venture funding in March 2018.
  • Unchained Labs's estimated revenue per employee is $193,750
  • Unchained Labs's total funding is $285M.

Employee Data

  • Unchained Labs has 300 Employees.(i)
  • Unchained Labs grew their employee count by -2% last year.

Unchained Labs's People

NameTitleEmail/Phone
1
Founder and CEOReveal Email/Phone
2
Chief Commercial OfficerReveal Email/Phone
3
Chief Commercial OfficerReveal Email/Phone
4
Chief Commercial OfficerReveal Email/Phone
5
VP Global SalesReveal Email/Phone
6
VP Workflow SalesReveal Email/Phone
7
Head Science and ApplicationsReveal Email/Phone
8
Head Biology R&DReveal Email/Phone
9
VP FinanceReveal Email/Phone
10
VP OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Unchained Labs?

Here's the deal. We're all about helping biologics researchers break free from tools that just don't cut it. Unleashing problem-tackling products that make a huge difference in the real science they do every day. That's our mantra, our promise and we own it. We are located in Pleasanton, CA and can be found online at www.unchainedlabs.com.

keywords:Biotechnology,Healthcare,Medical Diagnostics,Pharmaceuticals

$285M

Total Funding

300

Number of Employees

$58.1M

Revenue (est)

-2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Unchained Labs News

2022-04-13 - Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., Strengthens Board of Directors with Appointment of Highly Accomplished Pharmaceutical and Biotechnology Executive, Laura Hamill

She is a member of the boards of directors of BB Biotech, AnaptysBio, Inc., Pardes Biosciences, Y-mAbs Therapeutics, Inc., and Unchained Labs, a...

2022-04-06 - Unagi is a state of total awareness…and Unchained Labs ...

Unagi is a state of total awareness…and Unchained Labs' new benchtop buffer exchange platform! UNCHAINED_LABS_Logo. News provided by. Unchained...

2021-07-01 - Unchained Labs does it again for gene therapy and vaccine researchers, adds nanoparticle suite to Stunner

PLEASANTON, Calif., July 1, 2021 /PRNewswire/ -- Unchained Labs, the life sciences company that's all about getting biologics and gene therapy researchers the right tools for the job, launched a new application suite for the characterization of nanoparticles on Stunner today. Stunner is alread ...

2021-01-11 - Unchained Labs sticks it to viruses, launches new mRNA vaccine application on Stunner!

PLEASANTON, Calif., Jan. 11, 2021 /PRNewswire/ -- Unchained Labs, the life sciences company that's all about getting researchers the right tool for the job, launched its new mRNA vaccine application on Stunner today. Stunner is the only platform that can simultaneously quantify the total amoun ...

2020-10-06 - Unchained Labs launches the ultimate gene therapy tool; tackle AAV titer, empty/full ratio and more with Stunner!

PLEASANTON, Calif., Oct. 6, 2020 /PRNewswire/ -- Unchained Labs, the life sciences company that's all about getting researchers the right tool for the job, launched its new gene therapy quantification application on Stunner today. Stunner is the first platform that gives researchers a full rea ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$55.5M306N/AN/A
#2
$66.2M3217%N/A
#3
$87.3M348-7%N/A
#4
$118.8M3528%N/A
#5
$81.5M362-2%N/A

Unchained Labs Funding

DateAmountRoundLead InvestorsReference
2015-02-13$25.0MANovo VenturesArticle
2015-06-05$6.0MANovo VenturesArticle
2016-02-19$25.0MBNovo VenturesArticle
2017-07-03$13.0MUndisclosedArticle
2018-03-28$17.0MDMultipleArticle